NASDAQ: BRVE
Braveheart Bio, Inc.
$25.50
▼ -1.94 (-7.07%)as of 2026-08-31
1-year price · 19 sessions
Key stats
52-week range$25.50
$18.00$30.00
Today
- Open
- 27.95
- Day high
- 27.95
- Day low
- 24.31
- Prev close
- 27.44
- Volume
- 806K
Valuation
- Mkt cap
- $1.8B
- P/E (TTM)
- —
- EPS (TTM)
- —
- P/B
- —
- P/S
- —
Dividend
- Yield
- —
- Per share
- —
Insider & institutional activity · SEC Form 4 / 13F
- ▲Insiders net buying $159.0M over the last 3 months (13 open-market buys, 0 sales)
- ◆Cluster buying — multiple insiders bought within days
Braveheart Bio, Inc. (BRVE) is a Healthcare company listed on NASDAQ. Over the trailing 3 months, insiders filed 13 open-market buys and 0 sales (SEC Form 4).
Braveheart Bio, Inc. (BRVE) financials & analyst ratings
Fundamentals (TTM)
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
Growth & returns
Revenue growth—
Revenue growth (fwd)—
EPS growth—
Return on equity—
Return on assets—
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
BRVE insider trading activity (SEC Form 4)
Sentiment
100/100
Buys (3m)
13
Sells (3m)
0
Net (3m)
$159.0M
Insiders buyingCluster buying
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 11, 2026 | AH Bio Fund IV, L.P.10 percent owner | Buy | 1,100,000 | $18.00 |
| Aug 11, 2026 | Chimovits Erezdirector, 10 percent owner: | Buy | 1,666,667 | $18.00 |
| Aug 11, 2026 | Chimovits Erezdirector, 10 percent owner: | Buy | 273,333 | $18.00 |
| Aug 11, 2026 | ORBIMED ADVISORS LLCdirector, 10 percent owner: | Buy | 1,666,667 | $18.00 |
| Aug 11, 2026 | ORBIMED ADVISORS LLCdirector, 10 percent owner: | Buy | 273,333 | $18.00 |
| Aug 7, 2026 | Chimovits Erezdirector, 10 percent owner: | Grant | 30,000 | $18.00 |
| Aug 7, 2026 | Viehbacher Christopherdirector | Buy | 83,333 | $18.00 |
| Aug 7, 2026 | Viehbacher Christopherdirector | Grant | 30,000 | $18.00 |
| Aug 7, 2026 | Malek David Idirector | Buy | 4,166 | $18.00 |
| Aug 7, 2026 | Malek David Idirector | Grant | 30,000 | $18.00 |
| Aug 7, 2026 | Anderson Michele A.officer: Chief Development Officer | Buy | 1,111 | $18.00 |
| Aug 7, 2026 | Forbion Growth Opportunities Fund III Cooperatief U.A.10 percent owner | Buy | 1,920,000 | $18.00 |
| Aug 7, 2026 | Murdoch Travisdirector, officer: CEO and President | Buy | 83,333 | $18.00 |
| Aug 7, 2026 | Murdoch Travisdirector, officer: CEO and President | Grant | 550,000 | $19.80 |
| Aug 7, 2026 | Bos Jasperdirector | Grant | 30,000 | $18.00 |
Source: BRVE SEC Form 4 filings, latest Aug 11, 2026. For informational purposes only — not investment advice.
See the full BRVE insider & 13F page →Track BRVE with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free